These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36751523)

  • 1. Drug Development in Soft Tissue Sarcomas: Novel Targets and Recent Early Phase Trial Results.
    Achenbach E; Lai D; Sen S
    J Immunother Precis Oncol; 2020 May; 3(2):83-89. PubMed ID: 36751523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecularly targeted therapies in adult soft tissue sarcomas: present approach and future directions.
    Aranha O; Agulnik M
    Expert Opin Ther Targets; 2008 Feb; 12(2):197-207. PubMed ID: 18208368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapies for the treatment of soft tissue sarcoma.
    Fuchs JW; Schulte BC; Fuchs JR; Agulnik M
    Front Oncol; 2023; 13():1122508. PubMed ID: 36969064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapies for soft-tissue sarcomas.
    Levard A; Tassy L; Cassier PA
    Hematol Oncol Clin North Am; 2013 Oct; 27(5):1063-78. PubMed ID: 24093176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision Oncology in Sarcomas: Divide and Conquer.
    Carmagnani Pestana R; Groisberg R; Roszik J; Subbiah V
    JCO Precis Oncol; 2019; 3():. PubMed ID: 32914012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
    Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
    Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy in bone and soft tissue sarcoma in children and adolescents.
    Thompson PA; Chintagumpala M
    Curr Oncol Rep; 2012 Apr; 14(2):197-205. PubMed ID: 22302601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
    Nathenson MJ; Conley AP; Sausville E
    Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of tissue-agnostic approvals for patients with sarcoma.
    Pestana RC; Beal JR; Parkes A; Hamerschlak N; Subbiah V
    Trends Cancer; 2022 Feb; 8(2):135-144. PubMed ID: 34887213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE database.
    Pestana RC; Serrano C
    Front Oncol; 2022; 12():1079909. PubMed ID: 36741731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular classification of soft tissue sarcomas and its clinical applications.
    Jain S; Xu R; Prieto VG; Lee P
    Int J Clin Exp Pathol; 2010 Apr; 3(4):416-28. PubMed ID: 20490332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapies in soft tissue sarcoma.
    Vincenzi B; Frezza AM; Santini D; Tonini G
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):237-48. PubMed ID: 20465449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.
    Todd R; Lunec J
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):939-48. PubMed ID: 18533803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and advancing systemic treatment options for soft tissue sarcomas.
    Harris SJ; Benson C; Jones RL
    Expert Opin Pharmacother; 2015; 16(13):2023-37. PubMed ID: 26255951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical relevance of molecular genetics in soft tissue sarcomas.
    Ordóñez JL; Osuna D; García-Domínguez DJ; Amaral AT; Otero-Motta AP; Mackintosh C; Sevillano MV; Barbado MV; Hernández T; de Alava E
    Adv Anat Pathol; 2010 May; 17(3):162-81. PubMed ID: 20418671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.
    Drugs R D; 2006; 7(5):317-28. PubMed ID: 16922593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics.
    Varshney J; Subramanian S
    Front Mol Biosci; 2015; 2():31. PubMed ID: 26137468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Stem Cells in Soft-Tissue Sarcomas.
    Martínez-Delgado P; Lacerenza S; Obrador-Hevia A; Lopez-Alvarez M; Mondaza-Hernandez JL; Blanco-Alcaina E; Sanchez-Bustos P; Hindi N; Moura DS; Martin-Broto J
    Cells; 2020 Jun; 9(6):. PubMed ID: 32532153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of finding new therapeutic avenues in soft tissue sarcomas.
    Kasper B
    Clin Sarcoma Res; 2019; 9():5. PubMed ID: 31007895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of soft tissue sarcomas of the extremities with radiologic-pathologic correlation.
    Ramakrishnan K; Levy N; Goldbach A; Nagarathinam R; Ali S; Ling S; Jonnalagadda P
    Curr Probl Diagn Radiol; 2022; 51(6):868-877. PubMed ID: 35654634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.